We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

HRSA Weighs Next Steps On 340B 'Mega-Reg' After Court Overturns Orphan Drug Suit

11 June 2014

InsideHealthPolicy

A HRSA official told stakeholders Tuesday (June 10) the agency is weighing the impact of a recent court decision that some say could limit the agency's ability to proceed with a highly anticipated 340B "mega-reg" laying out the parameters of the drug discount program.

Read more: HRSA Weighs Next Steps On 340B 'Mega-Reg' After Court Overturns Orphan Drug Suit

The team

Loading data